A dietition/nutritionist talks about staying one step ahead of malnutrition and unhealthy weight loss
In the New Year, you may be looking to turn over a new leaf. One goal may be to improve your nutrition. Many cancer survivors struggle with food issues. In fact, research shows that up to 80 percent of people with a cancer diagnosis are expected to experience malnutrition at some point during treatment. Even before a diagnosis, as many as 40 percent of people with cancer experience unhealthy weight loss. Unhealthy weight loss can lead to decreased response to treatment, delays in treatment, and reduced quality of life.
You can avoid these nutrition problems! Use new eating strategies to improve your health and wellbeing during cancer treatment. Start today by improving your nutrition IQ.
Here are seven food and cancer facts that you may not know:
1) You can’t get all the nutrition your body needs from juicing. This surprises many people because of the recent popularity of juicing. Juicing is low in protein. Cancer survivors may need extra dietary protein during treatment to combat muscle loss. Pump up your juices by adding a scoop of protein powder, 4-8 ounces of Greek yogurt, or egg white powder to your glass. Always remember, juicing is a great way to add fruits or vegetables to your diet, but should not be used to try to meet all of your nutrition needs.
A potential new therapeutic approach for blastic plasmacytoid dendritic cell neoplasm (BPDCN), a very rare form of blood cancer with no standard treatment, continues to show promise as it moves through early clinical trials.
The Leukemia & Lymphoma Society (LLS) has a long history of supporting the development of SL-401, a targeted therapy that has shown significant anti-tumor effects. The current trials by Stemline Therapeutics are being sponsored in part by over $3 million in LLS funding through the Therapy Acceleration Program (TAP). TAP is a strategic initiative to partner with biotechnology companies and speed the development of new therapies.
BPDCN is a rare aggressive disease of the bone marrow and blood cells that has few effective treatment options. The disease is frequently misdiagnosed and under-reported and its overall incidence is extremely low, accounting for 0.44% of all hematologic malignancies.
Because there is no widely accepted protocol for BPDCN, patients are often treated as leukemia or lymphoma patients. Those who relapse after chemotherapy have a particularly poor prognosis. LLS considers its support critical to the development of this therapy.
Survivorship Series: Fifteen years after being diagnosed, Laura reflects on getting back to "normal."
I am glad to be here. Literally.
Being a survivor is a good thing. I could have been six feet under, after being diagnosed with acute lymphoblastic leukemia (ALL) on December 16, 2000. I was 40 years old, raising two children with my husband Ron. Our daughter was almost 4 years old and our son was 16 months.
After I was diagnosed, I spoke with a survivor through The Leukemia & Lymphoma Society’s First Connection program. Hearing her voice on the phone gave me so much hope. She was seven years post-diagnosis. I told her, “I can’t wait to be on your side of the fence.” About two years later, I was, having gone through training to be a First Connection volunteer. It makes me feel good to help others. When I was in the hospital, my mother said to me, “Who knows? Maybe you will be a spokesperson for the cause someday.” I responded by telling her no way, I just wanted to get back to my life - I did not want to be a member of this club.